ArticleInvestigational new drugs2026
Evaluating pegenzileukin (SAR444245/THOR-707) in combination with pembrolizumab or cetuximab in advanced metastatic gastrointestinal cancer: the PEGATHOR phase 2 study.
William P Harris et al.PubMed ↗Publisher ↗
No numbers read from the abstract.